Budget Amount *help |
¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2013: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2012: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
Outline of Final Research Achievements |
Helper T-lymphocytes (Th cells) promotes immune-mediated inflammatory diseases, such as allergic asthma and rheumatoid arthritis. Signaling via IL-6 contributes to the development of the Th17 subset, which is one of major subpopulations of Th cells. Th17 cells activate neutrophils and are involved in autoimmune diseases. This study demonstrates that TRAF5 adaptor protein constitutively associates with a cytoplasmic region in the signaling transducing receptor for IL-6, gp130, to inhibit the IL-6 signaling and that TRAF5 works as an anti-inflammatory factor to limit immune responses mediated by pathogenic Th17 cells.
|